Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anges, Cartesian, Enlivex, Inventisbio, Janux, Kinevant Sciences, Mesoblast, Palisade, Roivant, Terns, Valneva, Vasomune.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Autolus, Galderma, Gilead, Hua, Maplight, Merus, MBX, Revolution Medicines, Senti, Soligenix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alector, PTC, Outlook.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Axsome, Cognition, Genentech, Maat, S. Biomedics, Urogen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Biohaven, Blue Lake, Cassava, IGC, Immix, In8bio, Merck & Co., Orbus, Plus, SCG.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascentage, Immune-onc.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Lapix, Lumos, Pyxis.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amacathera, Argenx, Melt, Newamsterdam, Novo Nordisk, Painreform, Pasithea, Quralis, Sage, Uvax, Virion.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aelis, Biogen, Bridgebio, Brii, Cardiol, Chemomab, Eli Lilly, Esperion, Genethon, GSK, Immunitybio, Incyte, Merck, Newamsterdam, Nicox, Ocugen, Pliant, Protagonist, Regenxbio, Rocket, Silence, Thermosome, Vir.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Alnylam, Anthos, Arbutus, Bridgebio, Cybin, Eli Lilly, Intellia, Neurogene.